---
title: Oxford Biomedica vs Minaris Advanced Therapies
slug_a: oxb
slug_b: wuxi-advanced-therapies
site: cdmo
review_signal_gate: closed
canonical_path: /compare/oxb/wuxi-advanced-therapies
---

# Oxford Biomedica vs Minaris Advanced Therapies

Side-by-side profile data from each company listing on this directory.

## Oxford Biomedica

- Profile: [/companies/oxb](/companies/oxb)

Oxford Biomedica — Global viral vector CDMO with 30 years of expertise in lentivirus, AAV, and adenovirus manufacturing. Provides end-to-end development and GMP-compliant manufacturing services from preclinical through commercial launch for cell and gene therapy programs.

Services: 12. Modalities: 4. Indications: 3. Locations: 17. Certifications: 1. The strongest documented coverage currently appears in locations (17).

### Services

- Upstream Processing
- Downstream Processing
- Viral Vector Manufacturing
- AAV Manufacturing
- Lentiviral Vector Manufacturing
- Cell Therapy Manufacturing
- Vaccine Manufacturing
- Sterile Fill-Finish & Aseptic Manufacturing
- Process Development
- Technology Transfer
- CMC Analytical Development
- CMC Regulatory Submission Support

### Modalities

- Cell Therapy
- Gene Therapy
- Vaccine
- AAV / Viral Vector Platform

### Development capabilities

- Analytical method development

### Manufacturing capabilities

- Drug Substance (DS)
- Drug Product (DP)
- Liquid Vials
- Max bioreactor: Mid-scale clinical (≤2,000 L)
- Expression: Mammalian
- Expression: Cell-Free
- Expression: Viral Vector
- Single-Use / Disposable
- Stainless Steel

## Minaris Advanced Therapies

- Profile: [/companies/wuxi-advanced-therapies](/companies/wuxi-advanced-therapies)

Minaris Advanced Therapies — Pure-play cell and gene therapy CDMO with over 25 years of GMP manufacturing, process development, and biosafety testing expertise. Serves advanced therapy innovators globally from early stage through commercialization.

Services: 15. Modalities: 6. Indications: 0. Locations: 14. Certifications: 6. The strongest documented coverage currently appears in services (15).

### Services

- Monoclonal Antibody (mAb) Manufacturing
- Recombinant Protein Manufacturing
- Cell-Line Development
- Viral Vector Manufacturing
- AAV Manufacturing
- Lentiviral Vector Manufacturing
- Cell Therapy Manufacturing
- Autologous Cell Therapy Manufacturing
- Allogeneic Cell Therapy Manufacturing
- Vaccine Manufacturing
- Process Development
- Technology Transfer
- CMC Analytical Development
- Quality Control Testing
- Stability Testing & Storage

### Modalities

- Biologics (Monoclonal Antibodies)
- Biologics (Other)
- Cell Therapy
- Gene Therapy
- Vaccine
- AAV / Viral Vector Platform

### Development capabilities

- Analytical method development
- ICH stability testing
- Cell line development

### Manufacturing capabilities

- Drug Substance (DS)
- Drug Product (DP)
- Expression: Mammalian
- Expression: Viral Vector